Dettol-maker Reckitt Benckiser sells Russia business four years after EU sanctions
The maker of Dettol and Durex has sold off one of its two Russian businesses after falling foul…
Britain’s pharma policy is a gift to Ireland
Share this article Here’s a fun fact for you: Ireland, a country of just over 5 million people,…
FDA approves Reckitt’s new Mucinex cold, flu medicine
Reckitt has received approval from the U.S. Food and Drug Administration for a long-lasting cold and flu symptom-relief…
AstraZeneca-Bristol Myers merger talks explained
Pharma investors reeled this week from reports that AstraZeneca held merger talks with U.S. rival Bristol Myers Squibb,…
AstraZeneca stock falls as investors balk at reported Bristol Myers tie-up
AstraZeneca shares dropped as much as 7% on Monday after reports that the company had discussed a potential…
AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report
A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player…
Business Watch: War doesn’t stop Gulf chemical makers; BMS and AstraZeneca reportedly in merger talks
Paint is better than it used to be. I was recently charged with painting an accent wall—the first…
AstraZeneca and Bristol Myers Squibb in reported merger talks that could create £300bn pharma giant
The two pharmaceutical firms have held discussions over a potential tie-up in recent months, according to a Financial…
AstraZeneca’s £300bn mega-merger talks signal new era of pharma consolidation – London Business News
AstraZeneca has held discussions with US rival Bristol Myers Squibb over a potential merger that could create one…
Astrazeneca explores $400bn megadeal with US rival
Monday 03 August 2026 7:36 am | Updated: Monday 03 August 2026 8:07 am Astrazeneca is plotting a merger…
AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
UK drugmaker AstraZeneca has been exploring a deal to combine with US rival Bristol Myers Squibb, the Financial Times reported on…
Sweeping job cuts at GSK to fund £400m Cambridge campus
Tuesday 28 July 2026 1:18 pm GSK is poised to slash its back office headcount to help fund…